Does PANITUMUMAB Cause Carcinoembryonic antigen increased? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Carcinoembryonic antigen increased have been filed in association with PANITUMUMAB (Vectibix). This represents 0.6% of all adverse event reports for PANITUMUMAB.
69
Reports of Carcinoembryonic antigen increased with PANITUMUMAB
0.6%
of all PANITUMUMAB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Carcinoembryonic antigen increased From PANITUMUMAB?
Of the 69 reports, 1 (1.4%) resulted in death, 11 (15.9%) required hospitalization.
Is Carcinoembryonic antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANITUMUMAB. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does PANITUMUMAB Cause?
Rash (1,392)
Diarrhoea (1,123)
Death (767)
Dermatitis acneiform (758)
Neutropenia (757)
Skin toxicity (728)
Neuropathy peripheral (613)
Hypomagnesaemia (611)
Nausea (608)
Disease progression (600)
What Other Drugs Cause Carcinoembryonic antigen increased?
RIBOCICLIB (143)
LETROZOLE (115)
CAPECITABINE (113)
FULVESTRANT (105)
BEVACIZUMAB (102)
REGORAFENIB (91)
OXALIPLATIN (88)
OSIMERTINIB (82)
PALBOCICLIB (78)
FLUOROURACIL (71)
Which PANITUMUMAB Alternatives Have Lower Carcinoembryonic antigen increased Risk?
PANITUMUMAB vs PANOBINOSTAT
PANITUMUMAB vs PANTOPRAZOLE
PANITUMUMAB vs PANTOPRAZOLE ANHYDROUS
PANITUMUMAB vs PANTOTHENIC ACID
PANITUMUMAB vs PAPAVERINE